| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910480237603321 |
|
|
Autore |
Riccomini Paul J |
|
|
Titolo |
Response to intervention in math [[electronic resource] /] / Paul J. Riccomini, Bradley S. Witzel |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Thousand Oaks, Calif., : Corwin |
|
London, : SAGE [distributor], c2010 |
|
|
|
|
|
|
|
|
|
ISBN |
|
1-4522-7319-7 |
1-4522-0753-4 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (169 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
|
|
Soggetti |
|
Curriculum planning |
Effective teaching |
Learning disabled children - Education |
Mathematical ability - Testing |
Mathematics - Study and teaching (Elementary) |
Mathematics - Study and teaching (Middle school) |
Electronic books. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Cover; Contents; Preface; Acknowledgments; About the Authors; Chapter 1 - What Is RTI, and Why Is It Important?; Chapter 2 - The RTI Process for Math: Getting Started; Chapter 3 - A Tiered Approach to More Effective Mathematics Instruction; Chapter 4 - Mathematics Interventions Overview; Chapter 5 - Number Sense and Initial Math Skills; Chapter 6 - Building Students' Proficiency With Whole Numbers; Chapter 7 - Fractions and Decimals; Chapter 8 - Teaching Problem Solving Strategically; Chapter 9 - The Importance of Teaching Mathematical Vocabulary; Chapter 10 - Next Steps in the RTI Process |
ReferencesIndex |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Response to Intervention (RTI) is a relatively new system for assessment and instruction that has promising potential for teaching mathematics. This text presents a discussion about RTI in mathematics and offers |
|
|
|
|
|
|
|
|
|
|
|
|
|
guidelines for teachers responsible for the planning, designing, and delivering of mathematics instructional programmes. |
|
|
|
|
|
|
2. |
Record Nr. |
UNISA996212363403316 |
|
|
Autore |
Shorr Ronald I |
|
|
Titolo |
Drugs for the geriatric patient [[electronic resource] /] / Ronald I. Shorr, Angela B. Hoth, Nathan Rawls |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Edinburgh, : Saunders Elsevier, c2007 |
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (1404 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
ShorrRonald I |
HothAngela B |
RawlsNathan |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Geriatric pharmacology |
Geriatrics |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
|
|
|
|
|
Nota di contenuto |
|
Front Cover; Drugs for the Geriatric Patient; Copyright Page; Dedication; Table of Contents; Introduction; Abbreviations; Medication use; Drugs; abacavir sulfate; abciximab; acamprosate calcium; acarbose; acebutolol hydrochloride; acetaminophen; acetaminophen; dichloralphenazone; isometheptene mucate; acetazolamide; acetic acid; acetylcysteine; acitretin; acyclovir; adalimumab; adefovir dipivoxil; adenosine; albuterol; alclometasone dipropionate; alefacept; alendronate sodium; alfuzosin hydrochloride; allopurinol; almotriptan malate; alprazolam; alprostadil (prostaglandin E1, PGE1) |
alteplase, recombinantaluminum chloride hexahydrate; aluminum salts group; amantadine hydrochloride; ambenonium chloride; amcinonide; amikacin sulfate; amiloride hydrochloride; aminocaproic acid; aminophylline/theophylline; aminosalicylic acid; amiodarone hydrochloride; amitriptyline hydrochloride; amlexanox; amlodipine besylate; ammonium lactate; amobarbital sodium; amoxapine; amoxicillin; amoxicillin/clavulanate potassium; amphetamine sulfate; amphotericin B / amphotericin B cholesteryl / amphotericin B lipid |
|
|
|
|
|
|
|
|
|
|
|
complex / liposomal amphotericin B; ampicillin; ampicillin/sulbactam sodium |
amprenaviramyl nitrite; anagrelide; anakinra; anastrozole; anthralin; apraclonidine hydrochloride; aprepitant; argatroban; aripiprazole; ascorbic acid; aspirin/acetylsalicylic acid/ASA; atazanavir sulfate; atenolol; atomoxetine hydrochloride; atorvastatin calcium; atovaquone; atropine sulfate; atropine sulfate; diphenoxylate hydrochloride; auranofin/aurothioglucose; aurothioglucose/gold sodium thiomalate; azathioprine; azelastine; azithromycin; aztreonam; bacitracin; baclofen; balsalazide disodium; becaplermin; beclomethasone dipropionate; belladonna alkaloids; belladonna and opium |
benazeprilbentoquatam; benzocaine; benzonatate; benztropine mesylate; benzylpenicilloyl polylysine; bepridil hydrochloride; betamethasone; betaxolol hydrochloride; bethanechol chloride; bimatoprost; biperiden hydrochloride; bisacodyl; bismuth subsalicylate; bisoprolol fumarate; bitolterol mesylate; bivalirudin; bosentan; bretylium tosylate; brimonidine tartrate; brinzolamide; bromfenac; bromocriptine mesylate; brompheniramine maleate; budesonide; bumetanide; buprenorphine; bupropion hydrochloride; buspirone hydrochloride; butalbital compound; butenafine hydrochloride; butoconazole nitrate |
butorphanol tartratecabergoline; caffeine; calcipotriene; calcitonin; calcitriol; calcium acetate/calcium carbonate/calcium chloride/calcium citrate/calcium glubionate/calcium gluconate; candesartan cilexetil; capreomycin sulfate; capsaicin; captopril; carbamazepine; carbamide peroxide; carbenicillin indanyl sodium; carbidopa; levodopa; carisoprodol; carteolol hydrochloride; carvedilol; cascara sagrada; castor oil; cefaclor; cefadroxil monohydrate; cefamandole nafate; cefazolin sodium; cefdinir; cefditoren pivoxil; cefepime hydrochloride; cefixime; cefoperazone sodium; cefotaxime sodium |
cefotetan disodium |
|
|
|
|
|
|
Sommario/riassunto |
|
This user-friendly, comprehensive drug reference, point-of-care usage -provides clinical information on more than 1000 drugs and their use in geriatric patients. In addition to dosage information and clinical indications, this reference also addresses the challenging issues of drug-drug and drug-disease interactions, polypharmacy, toxicity, compromised renal and hepatic function, withdrawal events, and more. Useful summary sections provide 'at a glance' conclusions, recommendations and clinical pearls.Get comprehensive guidance on all the drugs you could conceivably encounter in treati |
|
|
|
|
|
|
|
| |